β-lactamase gene expression in a penicillin-resistant Bacillus anthracis strain

Antimicrobial Agents and Chemotherapy

Volumn 48, Issue 12, 2004, Pages 4873-4877

  Chen, Yahua ^a   Tenover, Fred C ^b   Koehler, Theresa M ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; BETA LACTAMASE; CEFAZOLIN; CEFEPIME; CEFOTAXIME; CEFOTETAN; CEFOXITIN; CEFTAZIDIME; CEFTRIAXONE; MEROPENEM; PENICILLIN G; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM;

ANTIBIOTIC RESISTANCE; ARTICLE; BACILLUS ANTHRACIS; BACTERIAL GENE; BACTERIAL STRAIN; GENE EXPRESSION; GENE SEQUENCE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL;

BACILLUS ANTHRACIS; BETA-LACTAMASES; DNA PRIMERS; GENE EXPRESSION REGULATION, BACTERIAL; GENE EXPRESSION REGULATION, ENZYMOLOGIC; MICROBIAL SENSITIVITY TESTS; MOLECULAR SEQUENCE DATA; MUTATION; PENICILLIN RESISTANCE; PLASMIDS; PROMOTER REGIONS (GENETICS); REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, RIBOSOMAL, 16S; SOIL MICROBIOLOGY;

EID: 9644300997     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.48.12.4873-4877.2004     Document Type: Article

References (36)

1. Agaisse, H., and D. Lereclus. 1994. Structural and functional analysis of the promoter region involved in full expression of the cryIIIA toxin gene of Bacillus thuringiensis. Mol. Microbiol. 13:97-107.
2. Ausubel, F. M., R. Brent, R. E. Kingston, D. D. Moore, J. G. Seidman, J. A. Smith, and K. Struhl. 1996. Current protocols in molecular biology. John Wiley & Sons, New York, N.Y.
3. Bakici, M. Z., N. Elaldi, M. Bakir, I. Dokmetas, M. Erandac, and M. Turan. 2002. Antimicrobial susceptibility of Bacillus anthracis in an endemic area. Scand. J. Infect. Dis. 34:564-566.
4. Bernstein, A., K. W. Nickerson, and R. A. Day. 1967. Thermal penicillinase derepression and temperature dependence of penicillinase production: inducible and constitutive strains of Bacillus cereus. Arch. Biochem. Biophys. 119:50-54.
5. Bradaric, N., and V. Punda-Polic. 1992. Cutaneous anthrax due to penicillin-resistant Bacillus anthracis transmitted by an insect bite. Lancet 340:306-307.
6. Cavallo, J.-D., F. Ramisse, M. Girardet, J. Vaissaire, M. Mock, and E. Hernandez. 2002. Antibiotic susceptibilities of 96 isolates of Bacillus anthracis isolated in France between 1994 and 2000. Antimicrob. Agents Chemother. 46:2307-2309.
7. Chen, Y., J. Succi, F. C. Tenover, and T. M. Koehler. 2003. β-Lactamase genes of the penicillin-susceptible Bacillus anthracis Sterne strain. J. Bacteriol. 185:823-830.
8. Coker, P. R., K. L. Smith, and M. E. Hugh-Jones. 2002. Antimicrobial susceptibilities of diverse Bacillus anthracis isolates. Antimicrob. Agents Chemother. 46:3843-3845.
9. Dai, Z., J.-C. Sirard, M. Mock, and T. M. Koehler. 1995. The atxA gene product activates transcription of the anthrax toxin genes and is essential for virulence. Mol. Microbiol. 16:1171-1181.
10. Doganay, M., and N. Aydin. 1991. Antimicrobial susceptibility of Bacillus anthracis. Scand. J. Infect. Dis. 23:333-335.
11. Filee, P., K. Benlafya, M. Delmarcelle, G. Moutzourelis, J. M. Frere, A. Brans, and B. Joris. 2002. The fate of the BlaI repressor during the induction of the Bacillus licheniformis BlaP beta-lactamase. Mol. Microbiol. 44:685-694.
12. Friedlander, A. M., S. L. Welkos, M. L. Pitt, J. W. Ezzell, P. L. Worsham, K. J. Rose, B. E. Ivins, J. R. Lowe, G. B. Howe, P. Mikesell, et al. 1993. Postexposure prophylaxis against experimental inhalation anthrax. J. Infect. Dis. 167:1239-1243.
13. Gold, H. 1967. Treatment of anthrax. Fed. Proc. 26:1563-1568.
14. Green, B. D., L. Battisti, T. M. Koehler, C. B. Thorne, and B. E. Ivins. 1985. Demonstration of a capsule plasmid in Bacillus anthracis. Infect. Immun. 49:291-297.
15. Hoffmaster, A. R., and T. M. Koehler. 1999. Autogenous regulation of the Bacillus anthracis pag operon. J. Bacteriol. 181:4485-4492.
16. Inglesby, T. V., T. O'Toole, D. A. Henderson, J. G. Bartlett, M. S. Ascher, E. Eitzen, A. M. Friedlander, J. Gerberding, J. Hauer, J. Hughes, J. McDade, M. T. Osterholm, G. Parker, T. M. Perl, P. K. Russell, and K. Tonat. 2002. Anthrax as a biological weapon, 2002: updated recommendations for management. JAMA 287:2236-2252.
17. Jackson, P. J., M. E. Hugh-Jones, D. M. Adair, G. Green, K. K. Hill, C. R. Kuske, L. M. Grinberg, F. A. Abramova, and P. Keim. 1998. PCR analysis of tissue samples from the 1979 Sverdlovsk anthrax victims: the presence of multiple Bacillus anthracis strains in different victims. Proc. Natl. Acad. Sci. USA 95:1224-1229.
18. 2 and a frans-acting element activate transcription from one of two promoters. J. Bacteriol. 176:586-595.
19. Koshimizu, K., M. Ogata, and K. Ishida. 1972. Penicillin-resistant anthrax bacilli isolated from a dead dairy cow. Jpn. Vet. Soc. J. 25:184-189.
20. Lalitha, M. K., and M. K. Thomas. 1997. Penicillin resistance in Bacillus anthracis. Lancet 349:1522.
21. Lightfoot, N. F., R. J. D. Scott, and P. C. B. Turnbull. 1990. Antimicrobial susceptibility of Bacillus anthracis: proceedings of the International Workshop on Anthrax. Salisbury Med. Bull. 68(Suppl.):95-98.
22. Magdalena, J., C. Gerard, B. Joris, M. Forsman, and J. Dusart. 1997. The two β-lactamase genes of Streptomyces cacaoi, blaL and blaU, are under the control of the same regulatory system. Mol. Gen. Genet. 255:187-193.
23. Materon, I. C., A. M. Queenan, T. M. Koehler, K. Bush, and T. Palzkill. 2003. Biochemical characterization of β-lactamases Bla1 and Bla2 from Bacillus anthracis. Antimicrob. Agents Chemother. 47:2040-2042.
24. McSwiggan, D. A., K. K. Hussain, and I. O. Taylor. 1974. A fatal case of cutaneous anthrax. J. Hyg. 73:151-156.
25. Mohammed, M. J., C. K. Marston, T. Popovic, R. S. Weyant, and F. C. Tenover. 2002. Antimicrobial susceptibility testing of Bacillus anthracis: comparison of results obtained by using the National Committee for Clinical Laboratory Standards broth microdilution reference and Etest agar gradient diffusion methods. J. Clin. Microbiol. 40:1902-1907.
26. Odendaal, M. W., P. M. Pieterson, V. de Vos, and A. D. Botha. 1991. The antibiotic sensitivity patterns of Bacillus anthracis isolated from the Kruger National Park. Onderstepoort J. Vet. Res. 58:17-19.
27. Palmer, B. R., and M. G. Marinus. 1994. The dam and dem strains of Escherichia coll - a review. Gene 143:1-12.
28. Perez-Casal, J., M. G. Caparon, and J. R. Scott. 1991. Mry, a trans-acting positive regulator of the M protein gene of Streptococcus pyogenes with similarity to the receptor proteins of two-component regulatory systems. J. Bacteriol. 173:2617-2624.
29. Philippon, A., J. Dusart, B. Joris, and J. M. Frere. 1998. The diversity, structure and regulation of β-lactamases. Cell. Mol. Life Sci. 54:341-346.
30. Raskin, C., C. Gerard, S. Donfut, E. Giannotta, G. Van Driessche, J. Van Beeumen, and J. Dusart. 2003. BlaB, a protein involved in the regulation of Streptomyces cacaoi β-lactamases, is a penicillin-binding protein. Cell. Mol. Life Sci. 60:1460-1469.
31. Saile, E., and T. M. Koehler. 2002. Control of anthrax toxin gene expression by the transition state regulator abrB. J. Bacteriol. 184:370-380.
32. Severn, M. 1976. A fatal case of pulmonary anthrax. Br. Med. J. 1:748.
33. Sterne, M. 1939. The use of anthrax vaccines prepared from avirulent (uncapsulated) variants of Bacillus anthracis. Onderstepoort J. Vet. Sci. Anim. Ind. 13:307-312.
34. Thorne, C. B. 1993. Bacillus anthracis, p. 113-124. In A. L. Sonenshein, J. A. Hoch, and R. Losick (ed.), Bacillus subtilis and other gram-positive bacteria: biochemistry, physiology, and molecular genetics. American Society for Microbiology, Washington, D.C.
35. Thorne, C. B. 1985. Genetics of Bacillus anthracis, p. 56-62. In L. Leive (ed.), Microbiology. American Society for Microbiology, Washington, D.C.
36. Zhang, H. Z., C. J. Hackbarth, K. M. Chansky, and H. F. Chambers. 2001. A proteolytic transmembrane signaling pathway and resistance to β-lactams in staphylococci. Science 291:1962-1965.